<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">465777473</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180323111946.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170327e19901101xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF00918482</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF00918482</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Taxol treatment of experimental proliferative vitreoretinopathy</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Stewart Daniels, Kevin Coonley, Marc Yoshizumi]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Taxol is a potent stabilizer of microtubules, and inhibitor of in vitro replication, migration, and contraction of fibroblasts. It has been found to limit the development of experimental tractional retinal detachments in nonvitrectomized rabbit eyes. We used taxol in vitrectomized, phakic rabbit eyes with experimentally induced proliferative vitreoretinopathy and tractional retinal detachments. Taxol was dissolved in 30% DMSO because of poor aqueous solubility. A single 0.1 ml intravitreal dose of 2 × 10−4 M taxol in 30% DMSO was injected immediately after 250000 heterologous corneal fibroblasts had been injected; 0.1 ml of 30% DMSO was injected into control eyes. Taxol reduced the incidence of tractional retinal detachments seen 3-4 weeks later. When taxol injection was delayed for 3 days after the initial intravitreal injection of fibroblasts into nonvitrectomized eyes, the extent of retinal detachments was reduced, but the incidence of retinal detachment was unchanged from the untreated eyes at the end of 4 weeks. These data indicate that taxol may be most useful when given early in the course of proliferative vitreoretinopathy.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag, 1990</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Daniels</subfield>
   <subfield code="D">Stewart</subfield>
   <subfield code="u">Vitreoretinal Division, Jules Stein Eye Institute, University of California, Los Angeles, 200 Stein Plaza, 90024-7007, Los Angeles, CA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Coonley</subfield>
   <subfield code="D">Kevin</subfield>
   <subfield code="u">Vitreoretinal Division, Jules Stein Eye Institute, University of California, Los Angeles, 200 Stein Plaza, 90024-7007, Los Angeles, CA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Yoshizumi</subfield>
   <subfield code="D">Marc</subfield>
   <subfield code="u">Vitreoretinal Division, Jules Stein Eye Institute, University of California, Los Angeles, 200 Stein Plaza, 90024-7007, Los Angeles, CA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Graefe's Archive for Clinical and Experimental Ophthalmology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">228/6(1990-11-01), 513-516</subfield>
   <subfield code="x">0721-832X</subfield>
   <subfield code="q">228:6&lt;513</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">228</subfield>
   <subfield code="o">417</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF00918482</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF00918482</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Daniels</subfield>
   <subfield code="D">Stewart</subfield>
   <subfield code="u">Vitreoretinal Division, Jules Stein Eye Institute, University of California, Los Angeles, 200 Stein Plaza, 90024-7007, Los Angeles, CA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Coonley</subfield>
   <subfield code="D">Kevin</subfield>
   <subfield code="u">Vitreoretinal Division, Jules Stein Eye Institute, University of California, Los Angeles, 200 Stein Plaza, 90024-7007, Los Angeles, CA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Yoshizumi</subfield>
   <subfield code="D">Marc</subfield>
   <subfield code="u">Vitreoretinal Division, Jules Stein Eye Institute, University of California, Los Angeles, 200 Stein Plaza, 90024-7007, Los Angeles, CA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Graefe's Archive for Clinical and Experimental Ophthalmology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">228/6(1990-11-01), 513-516</subfield>
   <subfield code="x">0721-832X</subfield>
   <subfield code="q">228:6&lt;513</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">228</subfield>
   <subfield code="o">417</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
